子宫内膜异位症：一种需要新治疗选择的炎症性疾病。
Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options.
机构信息
Société de Recherche pour l'Infertilité (SRI), 143 Avenue Grandchamp, 1150 Brussels, Belgium.
Université Catholique de Louvain, 1200 Brussels, Belgium.
出版信息
Int J Mol Sci. 2022 Jan 28;23(3):1518. doi: 10.3390/ijms23031518.
Abstract
Endometriosis, defined as the presence of endometrium-like tissue outside the uterus, is estimated to affect 10% of women of reproductive age [...].
摘要
子宫内膜异位症定义为子宫内膜样组织出现在子宫以外的部位，估计有 10%的育龄期妇女受其影响[...]。
相似文献
1
Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options.子宫内膜异位症：一种需要新治疗选择的炎症性疾病。
Int J Mol Sci. 2022 Jan 28;23(3):1518. doi: 10.3390/ijms23031518.
2
Curcumin and endometriosis: Review on potential roles and molecular mechanisms.姜黄素与子宫内膜异位症：潜在作用和分子机制的综述。
Biomed Pharmacother. 2018 Jan;97:91-97. doi: 10.1016/j.biopha.2017.10.119. Epub 2017 Nov 6.
3
Endometriosis Treatment: Role of Natural Polyphenols as Anti-Inflammatory Agents.子宫内膜异位症的治疗：天然多酚类化合物作为抗炎剂的作用。
Nutrients. 2023 Jun 30;15(13):2967. doi: 10.3390/nu15132967.
4
β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility.β-石竹烯可使子宫内膜异位症大鼠模型中的子宫内膜植入物消退，而不影响生育能力。
Eur J Pharmacol. 2013 Feb 28;702(1-3):12-9. doi: 10.1016/j.ejphar.2013.01.011. Epub 2013 Jan 23.
5
17β-estradiol and lipopolysaccharide additively promote pelvic inflammation and growth of endometriosis.17β-雌二醇和脂多糖可协同促进盆腔炎症和子宫内膜异位症的生长。
Reprod Sci. 2015 May;22(5):585-94. doi: 10.1177/1933719114556487. Epub 2014 Oct 29.
6
The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial.白藜芦醇对子宫内膜异位症妇女 MMP-2 和 MMP-9 表达的调节作用：一项随机探索性试验。
Gynecol Endocrinol. 2019 Aug;35(8):719-726. doi: 10.1080/09513590.2019.1576612. Epub 2019 Feb 19.
7
Clotrimazole is effective for the regression of endometriotic implants in a Wistar rat experimental model of endometriosis.克霉唑对子宫内膜异位症 Wistar 大鼠实验模型中子宫内膜异位症种植的消退有效。
Mol Cell Endocrinol. 2018 Nov 15;476:17-26. doi: 10.1016/j.mce.2018.04.005. Epub 2018 Apr 22.
8
Macrophages display proinflammatory phenotypes in the eutopic endometrium of women with endometriosis with relevance to an infectious etiology of the disease.子宫内膜异位症患者在位子宫内膜中的巨噬细胞呈现促炎表型，与该疾病的感染病因有关。
Fertil Steril. 2019 Dec;112(6):1118-1128. doi: 10.1016/j.fertnstert.2019.08.060.
9
Resveratrol suppresses inflammatory responses in endometrial stromal cells derived from endometriosis: a possible role of the sirtuin 1 pathway.白藜芦醇抑制子宫内膜异位症来源的子宫内膜基质细胞中的炎症反应：沉默调节蛋白1途径的可能作用。
J Obstet Gynaecol Res. 2014 Mar;40(3):770-8. doi: 10.1111/jog.12252. Epub 2013 Dec 10.
10
Emerging drugs in endometriosis.子宫内膜异位症的新兴药物
Expert Opin Emerg Drugs. 2006 Sep;11(3):503-24. doi: 10.1517/14728214.11.3.503.
引用本文的文献
1
Risk of neurodevelopmental disorders in the offspring of mothers with a history of endometriosis in Taiwanese women.台湾女性子宫内膜异位症病史患者后代患神经发育障碍的风险
Brain Behav Immun Health. 2025 Jun 20;47:101038. doi: 10.1016/j.bbih.2025.101038. eCollection 2025 Aug.
2
[Mechanisms of Neiyiting Decoction in Preventing Postoperative Recurrence of Endometriosis by Inhibiting Macrophage M1 Polarization Through the TREM1/TLR4/NF-κB Signaling Pathway].[内异停方通过TREM1/TLR4/NF-κB信号通路抑制巨噬细胞M1极化预防子宫内膜异位症术后复发的机制]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):371-381. doi: 10.12182/20250360601.
3
Association of COX-2 Selectivity in Pain Medication Use with Endometriosis Incidence: Retrospective Cohort Study.止痛药物使用中COX - 2选择性与子宫内膜异位症发病率的关联：回顾性队列研究
Yonsei Med J. 2025 Jun;66(6):374-382. doi: 10.3349/ymj.2024.0255.
4
Impact of combining laparoscopy with traditional Chinese medicine on oxidative stress in endometriosis-related infertility: A systematic review and meta-analysis.腹腔镜联合中医对子宫内膜异位症相关性不孕氧化应激的影响：一项系统评价与荟萃分析
Medicine (Baltimore). 2025 Apr 11;104(15):e41692. doi: 10.1097/MD.0000000000041692.
5
Dual targeting of CXCR4 and EZH2 in endometriosis.子宫内膜异位症中CXCR4和EZH2的双重靶向作用
iScience. 2025 Mar 1;28(4):112143. doi: 10.1016/j.isci.2025.112143. eCollection 2025 Apr 18.
6
Nanomicelle curcumin improves oxidative stress, inflammatory markers, and assisted reproductive techniques outcomes in endometriosis cases: a randomized clinical trial.纳米胶束姜黄素改善子宫内膜异位症患者的氧化应激、炎症标志物及辅助生殖技术结局：一项随机临床试验
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 15. doi: 10.1007/s00210-025-03958-7.
7
Unlocking the Potential: How Flavonoids Affect Angiogenesis, Oxidative Stress, Inflammation, Proliferation, Invasion, and Alter Receptor Interactions in Endometriosis.释放潜能：黄酮类化合物如何影响子宫内膜异位症中的血管生成、氧化应激、炎症、增殖、侵袭及改变受体相互作用
Food Sci Nutr. 2024 Dec 7;13(1):e4607. doi: 10.1002/fsn3.4607. eCollection 2025 Jan.
8
Endometriosis: Future Biological Perspectives for Diagnosis and Treatment.子宫内膜异位症：诊断与治疗的未来生物学视角。
Int J Mol Sci. 2024 Nov 14;25(22):12242. doi: 10.3390/ijms252212242.
9
High prevalence of undiagnosed iron deficiency in endometriosis patients: A cross-sectional study.子宫内膜异位症患者中未诊断出的缺铁患病率：一项横断面研究。
Int J Gynaecol Obstet. 2025 Mar;168(3):1321-1327. doi: 10.1002/ijgo.15994. Epub 2024 Nov 20.
10
Molecular Regulator Driving Endometriosis Towards Endometrial Cancer: A Multi-Scale Computational Investigation to Repurpose Anti-Cancer drugs.分子调控因子推动子宫内膜异位症向子宫内膜癌的发展：一种用于重新利用抗癌药物的多尺度计算研究。
Cell Biochem Biophys. 2024 Dec;82(4):3367-3381. doi: 10.1007/s12013-024-01420-8. Epub 2024 Jul 23.
本文引用的文献
1
Pathogenesis of Endometriosis: New Insights into Prospective Therapies.子宫内膜异位症的发病机制：潜在治疗方法的新见解。
Int J Mol Sci. 2021 Oct 28;22(21):11700. doi: 10.3390/ijms222111700.
2
GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?GnRH 拮抗剂联合或不联合反向添加疗法：子宫内膜异位症治疗的新选择？
Int J Mol Sci. 2021 Oct 20;22(21):11342. doi: 10.3390/ijms222111342.
3
Ectopic Endometrium: The Pathologist's Perspective.异位子宫内膜：病理学家的视角。
Int J Mol Sci. 2021 Oct 11;22(20):10974. doi: 10.3390/ijms222010974.
4
-Acyl Dopamines Induce Apoptosis in Endometrial Stromal Cells from Patients with Endometriosis.酰基多巴胺诱导子宫内膜异位症患者的子宫内膜基质细胞凋亡。
Int J Mol Sci. 2021 Sep 30;22(19):10648. doi: 10.3390/ijms221910648.
5
New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments.内异症的新疗法：激素、非激素和非编码 RNA 治疗的综述。
Int J Mol Sci. 2021 Sep 28;22(19):10498. doi: 10.3390/ijms221910498.
6
Genetics and Inflammation in Endometriosis: Improving Knowledge for Development of New Pharmacological Strategies.子宫内膜异位症的遗传学和炎症：为新的药物治疗策略开发提供知识。
Int J Mol Sci. 2021 Aug 21;22(16):9033. doi: 10.3390/ijms22169033.
7
Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?内异症相关氧化应激是否能为新的治疗靶点铺平道路？
Int J Mol Sci. 2021 Jul 1;22(13):7138. doi: 10.3390/ijms22137138.
8
Intricate Connections between the Microbiota and Endometriosis.微生物群与子宫内膜异位症之间的复杂联系。
Int J Mol Sci. 2021 May 26;22(11):5644. doi: 10.3390/ijms22115644.
9
Autophagy and Mitophagy Promotion in a Rat Model of Endometriosis.子宫内膜异位症大鼠模型中自噬和线粒体自噬的促进作用。
Int J Mol Sci. 2021 May 11;22(10):5074. doi: 10.3390/ijms22105074.
10
Iron storage is significantly increased in peritoneal macrophages of endometriosis patients and correlates with iron overload in peritoneal fluid.子宫内膜异位症患者腹膜巨噬细胞中的铁储存显著增加，且与腹水中的铁过载相关。
Fertil Steril. 2009 May;91(5):1668-75. doi: 10.1016/j.fertnstert.2008.02.103. Epub 2008 Apr 8.
Zotero 插件